NTII

Neurobiological Technologies, Inc. NTII

NTII
Neurobiological Technologies, Inc. ANTH
Anthera Pharmaceuticals, Inc. GBIM
GlobeImmune, Inc. SYVC
Synovics Pharmaceuticals, Inc. OVIT
OncoVista Innovative Therapies, Inc. PZRXQ
PhaseRx, Inc. SNNAQ
Sienna Biopharmaceuticals, Inc. CMRA
Comera Life Sciences Holdings, Inc. RBSH
Rebus Holdings, Inc. COTQF
Cotinga Pharmaceuticals Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode NTII ANTH GBIM SYVC OVIT PZRXQ SNNAQ CMRA RBSH COTQF
6M 0.00 % 0.00 % -80.00 % 0.00 % 100.00 % 0.00 % 0.00 % -50.00 % 0.00 % 0.00 %
YTD 0.00 % -50.00 % -50.00 % 0.00 % 0.00 % -50.00 % 0.00 % -50.00 % -50.00 % 0.00 %
1Y 0.00 % 0.00 % -50.00 % 0.00 % 0.00 % -50.00 % 0.00 % -50.00 % 0.00 % 0.00 %
3Y 0.00 % 0.00 % -85.71 % 0.00 % 0.00 % 0.00 % 0.00 % -99.99 % -98.73 % 900.00 %
5Y -93.33 % -99.43 % -99.97 % 0.00 % -99.25 % -98.04 % -98.61 % -100.00 % -99.98 % -95.35 %
10Y -99.53 % -100.00 % -100.00 % 0.00 % -99.88 % -100.00 % -100.00 % -100.00 % -100.00 % -99.96 %
From the beginning -100.00 % -100.00 % -100.00 % 0.00 % -99.99 % -100.00 % -100.00 % -100.00 % -100.00 % -99.98 %

Dividend

Neurobiological Technologies, Inc.